Unknown

Dataset Information

0

Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa.


ABSTRACT:

Objective

To estimate the cost-effectiveness of daily oral tenofovir-based PrEP, with a protective effect against HSV-2 as well as HIV-1, among HIV-1 serodiscordant couples in South Africa.

Methods

We incorporated HSV-2 acquisition, transmission, and interaction with HIV-1 into a microsimulation model of heterosexual HIV-1 serodiscordant couples in South Africa, with use of PrEP for the HIV-1 uninfected partner prior to ART initiation for the HIV-1 1infected partner, and for one year thereafter.

Results

We estimate the cost per disability-adjusted life-year (DALY) averted for two scenarios, one in which PrEP has no effect on reducing HSV-2 acquisition, and one in which there is a 33% reduction. After a twenty-year intervention, the cost per DALY averted is estimated to be $10,383 and $9,757, respectively--a 6% reduction, given the additional benefit of reduced HSV-2 acquisition. If all couples are discordant for both HIV-1 and HSV-2, the cost per DALY averted falls to $1,445, which shows that the impact is limited by HSV-2 concordance in couples.

Conclusion

After a 20-year PrEP intervention, the cost per DALY averted with a reduction in HSV-2 is estimated to be modestly lower than without any effect, providing an increase of health benefits in addition to HIV-1 prevention at no extra cost. The small degree of the effect is in part due to a high prevalence of HSV-2 infection in HIV-1 serodiscordant couples in South Africa.

SUBMITTER: Jewell BL 

PROVIDER: S-EPMC4304839 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa.

Jewell Britta L BL   Cremin Ide I   Pickles Michael M   Celum Connie C   Baeten Jared M JM   Delany-Moretlwe Sinead S   Hallett Timothy B TB  

PloS one 20150123 1


<h4>Objective</h4>To estimate the cost-effectiveness of daily oral tenofovir-based PrEP, with a protective effect against HSV-2 as well as HIV-1, among HIV-1 serodiscordant couples in South Africa.<h4>Methods</h4>We incorporated HSV-2 acquisition, transmission, and interaction with HIV-1 into a microsimulation model of heterosexual HIV-1 serodiscordant couples in South Africa, with use of PrEP for the HIV-1 uninfected partner prior to ART initiation for the HIV-1 1infected partner, and for one y  ...[more]

Similar Datasets

| S-EPMC3913536 | biostudies-literature
| S-EPMC4191829 | biostudies-literature
| S-EPMC8266225 | biostudies-literature
| S-EPMC7370981 | biostudies-literature
| S-EPMC5980503 | biostudies-literature
| S-EPMC4415942 | biostudies-literature
| S-EPMC4267973 | biostudies-literature
| S-EPMC4568890 | biostudies-literature
| S-EPMC5564004 | biostudies-literature
| S-EPMC4865806 | biostudies-literature